FDA Announces Safety Monitoring Measures for the Essure Device
Measures include having women in the postmarket surveillance study followed for five years, not three
FDA Warns Companies on Unsafe, Unapproved Stem Cell Treatments
Patients contracting deadly infections at clinics offering the unapproved treatments
FDA: Teething Jewelry Linked to at Least One Infant Death
Threats from these products include choking, strangulation, injury to the mouth, infection
FDA: Fluoroquinolones Tied to Heart Vessel Ruptures, Tears
Patients at risk include those with hypertension or certain genetic disorders and the elderly
Affordable Care Act Sign-Ups Higher Than Expected
As of last Saturday's enrollment deadline, 8.5 million people in 39 states had enrolled
Restrictive, Obstructive Lung Disease Linked to Dementia Risk
Associations seen for both Alzheimer's disease-related dementia and cerebrovascular etiologies
Hospitalization for Upper GI Bleed Highest With Rivaroxaban
Upper gastrointestinal bleeding hospitalization risk lower for anticoagulant tx with PPI cotherapy
Structured Family-Centered Peds Rounds Improve Patient Safety
Forty percent decrease seen in harmful errors; decrease also in nonpreventable adverse events
Global Lifetime Risk for Stroke About 25 Percent in 2016
Estimated risk from age 25 years onward is 24.9 percent, with geographic variation in risk
ADA 2019 Standards of Care Emphasize Patient-Centered Care
Updates include use of SGLT-2 inhibitors and GLP-1 receptor agonists for T2DM, CVD; endorsed by ACC
